Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Board Change

15 Jul 2024 07:00

RNS Number : 3173W
Burberry Group PLC
15 July 2024
 

15 July 2024

BURBERRY GROUP PLC

("Burberry" or the "Company")

 

BOARD CHANGE

 

Burberry today announces the appointment of Joshua Schulman as Chief Executive Officer and Executive Director. Joshua replaces Jonathan Akeroyd who is stepping down and leaving the Company with immediate effect by mutual agreement with the Board.

An American national, Joshua, 52, joins Burberry with a track record of driving transformative growth and value creation as CEO of global luxury, fashion, and retail businesses.

Joshua was previously CEO of American fashion brands Michael Kors (2021-2022) and Coach where he also served as Brand President (2017-2020). Prior to this, at Neiman Marcus Group, he was President of Bergdorf Goodman for five years. From 2007 to 2012, Joshua was CEO of Jimmy Choo in London. Earlier, Joshua was Executive Vice President/ Worldwide Merchandising and Sales at Yves Saint Laurent and Worldwide Director/ Women's Ready To Wear at Gucci.

Joshua will join Burberry on 17 July 2024 and be based at the Company's headquarters in London. He will lead the Executive Committee and report to Burberry Chair Gerry Murphy and the Board of Directors.

Gerry Murphy commented: "I am pleased that Josh will be joining Burberry as our new Chief Executive Officer. Josh is a proven leader with an outstanding record of building global luxury brands and driving profitable growth. He has a strong understanding of our brand and shares our ambition to build on Burberry's unique creative heritage. His extensive experience in luxury and fashion will be key to realising Burberry's full potential."

"I would like to take this opportunity to thank Jonathan Akeroyd for the contribution he has made to Burberry. Jonathan has set out a clear strategy for growth that we will build on."

Joshua Schulman commented: "I am deeply honoured to join Burberry as Chief Executive Officer. Burberry is an extraordinary luxury brand, quintessentially British, equal parts heritage and innovation. Its original purpose to protect people from the weather is more relevant than ever. I look forward to working alongside Daniel Lee and the talented teams to drive global growth, delight our customers, and write the next chapter of the Burberry story."

This announcement contains information that qualified or may have qualified as inside information for the purposes of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). For the purposes of MAR, the person responsible for the release of this announcement on behalf of Burberry is Gemma Parsons, Company Secretary.

There are no other matters to be disclosed under listing rule 9.6.13R in relation to Joshua's appointment.

Additional information

About Joshua Schulman

· As CEO and Brand President of Coach, Joshua led a brand transformation focused on global cultural relevance, product innovation and digital growth, resulting in an inflection in sales and operating income.

· At Neiman Marcus Group, he was President of Bergdorf Goodman where he energised the New York retailer by renovating the landmark flagship while driving digital growth. Concurrently, he spearheaded the acquisition of MyTheresa.com.

· As CEO of Jimmy Choo, Joshua led the evolution of the shoe specialist into a global luxury brand. With a strategy of icons and innovation, he expanded the company's global footprint, growing sales and EBITDA 4X in five years.

· Joshua has also been on the board of Zimmermann, the Australian luxury brand and was a non-executive director of Farrow & Ball, the UK-based luxury paint and wall covering brand.

· Joshua attended New York University and Parsons School of Design. 

· Originally from Los Angeles, he is relocating to London from New York City.

 

Remuneration Arrangements

Joshua Schulman's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders at the AGM on 12 July 2023. His salary will be £1,200,000 per annum and he will be eligible for a target bonus of 100% of salary and maximum of 200% of salary and a Burberry Share Plan award of 162.5% of salary. His pension entitlement will align with arrangements for the majority of the UK workforce. On joining, he will be granted a recruitment share award of 300% of salary which is due to vest three years from his commencement date subject to a two-year holding period based on achieving performance conditions linked to shareholder value creation. The Company will also pay his costs associated with his relocation from New York. Full details will be disclosed in Burberry's FY 2024/25 Annual Report. 

 

 

Jonathan Akeroyd's departure will be treated in accordance with the Directors' Remuneration Policy and his service contract. He will not be eligible for a bonus for the current financial year and all unvested share awards will lapse in full. Full details will be disclosed on Burberry's website in compliance with Section 430(2B) of the Companies Act 2006 and in the Directors' Remuneration Report within the Company's Annual Report and Accounts for the year ended March 2025.

Annual General Meeting

As the Company's notice of Annual General Meeting 2024 (the "Notice") has already been issued, the Company confirms that resolution 5 to re-elect Jonathan Akeroyd as a director of the Company is now withdrawn. The withdrawal of this resolution does not otherwise affect the validity of the Notice, the proxy form or any proxy votes already submitted or any other resolutions. The numbering of all other resolutions proposed at the Annual General Meeting will remain unchanged. Any votes already cast in relation to resolution 5 are of no effect.

ENQUIRIES

Investors and analysts

020 3367 3524

Lauren Wu Leng

Head of Investor Relations

lauren.wuleng@burberry.com

Media

020 3367 3764

Andrew Roberts

SVP, Corporate Relations and Engagement

andrew.roberts@burberry.com

 

· This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

· Burberry is a British luxury brand, headquartered in London

· Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. ADR symbol OTC:BURBY. BURBERRY, the Equestrian Knight Device, the Burberry Check, and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOARIMLTMTTBBJI
Date   Source Headline
19th Mar 20207:00 amRNSUpdate on the Impact of COVID-19
6th Mar 20202:06 pmRNSDirector Declaration
5th Mar 20207:00 amRNSTreasury Shares Cancellation
4th Mar 202010:25 amRNSBlock listing Interim Review
2nd Mar 202012:39 pmRNSTotal Voting Rights
25th Feb 20205:13 pmRNSHolding(s) in Company
7th Feb 20203:55 pmRNSDirector/PDMR Shareholding
7th Feb 20207:00 amRNSUpdate on the Impact of Coronavirus
4th Feb 20204:05 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:54 amRNSTotal Voting Rights
31st Jan 20207:00 amRNSTransaction in Own Shares
30th Jan 20207:00 amRNSTransaction in Own Shares
29th Jan 20207:00 amRNSTransaction in Own Shares
27th Jan 20207:00 amRNSTransaction in Own Shares
24th Jan 20207:00 amRNSTransaction in Own Shares
23rd Jan 20207:00 amRNSTransaction in Own Shares
22nd Jan 20207:00 amRNSTransaction in Own Shares
22nd Jan 20207:00 amRNSBurberry Third Quarter Trading Statement
21st Jan 20207:00 amRNSTransaction in Own Shares
20th Jan 20207:00 amRNSTransaction in Own Shares
17th Jan 20207:00 amRNSTransaction in Own Shares
16th Jan 20207:00 amRNSTransaction in Own Shares
15th Jan 20207:00 amRNSTransaction in Own Shares
14th Jan 20207:00 amRNSTransaction in Own Shares
13th Jan 20207:00 amRNSTransaction in Own Shares
10th Jan 20207:00 amRNSTransaction in Own Shares
9th Jan 20207:00 amRNSTransaction in Own Shares
8th Jan 20207:00 amRNSTransaction in Own Shares
7th Jan 20207:00 amRNSTransaction in Own Shares
6th Jan 20207:00 amRNSTransaction in Own Shares
3rd Jan 20207:00 amRNSTransaction in Own Shares
2nd Jan 202011:03 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSTransaction in Own Shares
31st Dec 20197:00 amRNSTransaction in Own Shares
30th Dec 20197:00 amRNSTransaction in Own Shares
27th Dec 20197:00 amRNSTransaction in Own Shares
24th Dec 20197:00 amRNSTransaction in Own Shares
23rd Dec 201910:20 amRNSDirector/PDMR Shareholding
23rd Dec 20197:00 amRNSTransaction in Own Shares
20th Dec 20197:00 amRNSTransaction in Own Shares
19th Dec 20197:00 amRNSTransaction in Own Shares
18th Dec 20197:00 amRNSTransaction in Own Shares
17th Dec 20197:00 amRNSTransaction in Own Shares
16th Dec 20197:00 amRNSTransaction in Own Shares
13th Dec 20197:00 amRNSTransaction in Own Shares
12th Dec 20197:00 amRNSTransaction in Own Shares
11th Dec 20197:00 amRNSTransaction in Own Shares
10th Dec 20197:00 amRNSTransaction in Own Shares
9th Dec 20197:00 amRNSTransaction in Own Shares
6th Dec 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.